Baxter Healthcare Corporation Cardene IV in 0.83% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
The hazard: Labelling or manufacturing-practice failure
A labelling or good-manufacturing-practice failure prompted this notice. Pharmacies and patients both rely on the printed carton being right.
What the notice says: CGMP Deviations
Why it matters: The label, the strength printed on it, the barcode or the manufacturing records do not meet federal requirements. The practical danger is someone taking the wrong drug or the wrong dose while believing they have the right one.
Symptoms and when to call a doctor
If you may have taken a product that turned out to be a different drug or strength from the one on the label, call your prescriber, and call Poison Control on 1-800-222-1222 if you feel unwell. Describe what the pack said and what you actually took.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0813-2026
- Published
- September 9, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Baxter Healthcare Corporation
- Product type
- Prescription & OTC drugs
- Units affected
- N/A
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027.
Products covered by this recall
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.
Check your product
The notice names 10 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- NC177818
- NC188869
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 12
- 31
- 2026
- 2027. — N
NDC number
On the carton and again on the bottle or blister label.
- 43066-016-10
Package size
Match the net weight or the piece count on the front of the pack.
- 40 mg
- 200 mL
- 0.2 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Labelling
Baxter Healthcare Corporation — A labelling or good-manufacturing-practice failure prompted this notice. Pharmacies and patients both rely on the printed carton being right.
- Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
- If what you were dispensed does not match your prescription, call the pharmacy before taking another dose.
- Keep taking the medicine as prescribed unless the notice or your prescriber says otherwise.
- Return the affected pack to the pharmacy for a replacement from a good lot.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: Baxter Healthcare Corporation — 1 Baxter Pkwy, Deerfield, IL, 60015-4625
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Baxter Healthcare Corporation prescription & otc drugs recalled?
CGMP Deviations CGMP Deviations
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code NC177818, NC188869; best-by date 12 or 31. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ 40" MRS Surface recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class II · 25 days ago
Baxter Healthcare Corporation Brand Name: Volara System Product Name: Volara, HC recall: Contamination within the release test equipment flow path could have affected
Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to…
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ MRS Surface FOR Versacare recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ 36" MRS Surface recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class I · last month
Baxter Healthcare Corporation Dextrose Injection, USP, 70 %, 2000 mL bags recall: Presence of Particulate Matter: particulate matter identified as stainless
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose recall: CGMP Deviations
CGMP Deviations